1.
Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability
by Willemsen, Marjolein H
Journal of medical genetics, 2011-12, Vol.48 (12), p.810-818
2.
MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2
by Luo, Chonglin
Cancer letters, 2013, Vol.341 (2), p.240-247
3.
Melanoma biology and new targeted therapy
by Gray-Schopfer, Vanessa
Nature (London), 2007-02-22, Vol.445 (7130), p.851-857
4.
Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development： do all roads lead to Mitf
by Hou, Ling
Cell research, 2008, Vol.18 (12), p.1163-1176
5.
Vitamin E decreases bone mass by stimulating osteoclast fusion
by Fujita, Koji
Nature medicine, 2012-03-04, Vol.18 (4), p.589-594
6.
The enigma of the role of Protein inhibitor of Activated STAT3 (PIAS3) in the immune response
by Yagil, Zohar
Trends in immunology, 2010, Vol.31 (5), p.199-204
7.
Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?
by Jakobiec, Frederick A
American journal of ophthalmology, 2016, Vol.162, p.3-19.e1
8.
MITF, the Janus transcription factor of melanoma
by Koludrovic, Dana
Future oncology (London, England), 2013-02-01, Vol.9 (2), p.235-244
9.
Heterogeneity of Metastatic Melanoma: Correlation of MITF With Its Transcriptional Targets MLSN1, PEDF, HMB-45, and MART-1
by Zand, Sarvenaz
American journal of clinical pathology, 2016-09, Vol.146 (3), p.353-360
10.
Suppression of microphthalmia-associated transcription factor, but not NF-kappa B sensitizes melanoma specific cell death
by Mokhamatam, Raveendra B
Apoptosis (London), 2016-06-20, Vol.21 (8), p.928-940
11.
A novel method to predict regulatory regions based on histone mark landscapes in macrophages
by Nagy, Gergely
Immunobiology (1979), 2013, Vol.218 (11), p.1416-1427
12.
Down-regulation of tyrosinase,TRP-1,TRP-2 and MITF expressions by citrus press-cakes in murine B16 F10 melanoma
by Kim, Sang Suk
Asian Pacific journal of tropical biomedicine, 2013, Vol.3 (8), p.617-622
13.
Tumor strengths and frailties: Cancer SUMmOns Otto's metabolism
by Ohh, Michael
Nature medicine, 2012-01-06, Vol.18 (1), p.30-31
14.
Anti-melanogenic effects of δ-tocotrienol are associated with tyrosinase-related proteins and MAPK signaling pathway in B16 melanoma cells
by Ng, Lean-Teik
Phytomedicine (Stuttgart), 2014-06-15, Vol.21 (7), p.978-983
15.
Citrus flavanone naringenin enhances melanogenesis through the activation of Wnt/β-catenin signalling in mouse melanoma cells
by Huang, Yu-Chun
Phytomedicine (Stuttgart), 2011, Vol.18 (14), p.1244-1249
16.
Docosahexaenoic acid inhibits melanin synthesis in murine melanoma cells in vitro through increasing tyrosinase degradation
by Balcos, Marie Carmel
Acta pharmacologica Sinica, 2014, Vol.35 (4), p.489-495
17.
Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arth...
by Miyazaki, Masashi
Clinical rheumatology, 2007-02, Vol.26 (2), p.231-239
18.
Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells
by Yu, Ji Sun
Journal of biomedical science, 2010-08-24, Vol.17 Suppl 1 (Suppl 1), p.S45-S45
19.
Novel Splice Mutation in Microthalmia-Associated Transcription Factor in Waardenburg Syndrome
by Brenner, Laura
Genetic testing and molecular biomarkers, 2011-07-01, Vol.15 (7-8), p.525-529
20.
Chapter 1 The Physiological Role of Lysyl tRNA Synthetase in the Immune System
by Nechushtan, Hovav
Advances in Immunology, 2009, Vol.103, p.1-27
